Lighthouse Investment Partners’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-41,985
Closed -$3.03M 1010
2025
Q4
$3.03M Buy
+41,985
New +$2.71M 0.09% 273
2024
Q1
Sell
-65,362
Closed -$592K 449
2023
Q4
$592K Buy
+65,362
New +$437K 0.03% 250

Other funds holding RNAM

Lighthouse Investment Partners's RNAM Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 41,985 shares — an estimated $3.03M sold.

Lighthouse Investment Partners first reported a position in RNAM in Q4 2023 and held it in 2 quarters. The position peaked at $3.03M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 41,985 Avidity Biosciences shares in Q1 2026, an estimated $3.03M.
  • Lighthouse Investment Partners first reported a position in Avidity Biosciences in Q4 2023 and held it in 2 quarters.
  • Lighthouse Investment Partners's Avidity Biosciences position peaked at $3.03M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.